BIOMAT Database Logo BIOMAT Database Logo

Enzymic and interindividual differences in the human metabolism of heterocyclic amines. 1996

A R Boobis, and N J Gooderham, and R J Edwards, and S Murray, and A M Lynch, and M Yadollahi-Farsani, and D S Davies
Department of Clinical Pharmacology, Royal Postgraduate Medical School, London, United Kingdom.

Heterocyclic amines (HAs) present in cooked meat (PhIP and MeIQx) are activated only by CYP1A2 in the liver of most species, including man. This enzyme exhibits marked interindividual differences in its expression, due to induction and possibly also genetically. The absence of CYP1A2 appears to protect from HA-(PhIP and MeIQx) induced cancer, as exemplified by results in the cynomolgus monkey. Differences in the potency of these HAs are not due to differences in the kinetics of their activation. The catalytic efficiency of CYP1A2 towards HAs and their oxidative fate varies amongst species, in both cases increasing the susceptibility of humans compared to that of the rat. Interindividual and inter-organ differences in the further metabolism of N-hydroxy-HAs appear to be important determinants of cancer susceptibility, as does the glutathione S-transferase catalysed detoxication of esters of N-hydroxy-PhIP. There is a need for an effective means of quantifying the in vivo activation of HAs in man to enable the possible risk posed by these compounds to be assessed effectively.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008461 Meat Products Articles of food which are derived by a process of manufacture from any portion of carcasses of any animal used for food (e.g., head cheese, sausage, scrapple). Meat Product,Product, Meat,Products, Meat
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D011810 Quinoxalines Quinoxaline
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D003577 Cytochrome P-450 Enzyme System A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism. Cytochrome P-450,Cytochrome P-450 Enzyme,Cytochrome P-450-Dependent Monooxygenase,P-450 Enzyme,P450 Enzyme,CYP450 Family,CYP450 Superfamily,Cytochrome P-450 Enzymes,Cytochrome P-450 Families,Cytochrome P-450 Monooxygenase,Cytochrome P-450 Oxygenase,Cytochrome P-450 Superfamily,Cytochrome P450,Cytochrome P450 Superfamily,Cytochrome p450 Families,P-450 Enzymes,P450 Enzymes,Cytochrome P 450,Cytochrome P 450 Dependent Monooxygenase,Cytochrome P 450 Enzyme,Cytochrome P 450 Enzyme System,Cytochrome P 450 Enzymes,Cytochrome P 450 Families,Cytochrome P 450 Monooxygenase,Cytochrome P 450 Oxygenase,Cytochrome P 450 Superfamily,Enzyme, Cytochrome P-450,Enzyme, P-450,Enzyme, P450,Enzymes, Cytochrome P-450,Enzymes, P-450,Enzymes, P450,Monooxygenase, Cytochrome P-450,Monooxygenase, Cytochrome P-450-Dependent,P 450 Enzyme,P 450 Enzymes,P-450 Enzyme, Cytochrome,P-450 Enzymes, Cytochrome,Superfamily, CYP450,Superfamily, Cytochrome P-450,Superfamily, Cytochrome P450
D005511 Food Handling Any aspect of the operations in the preparation, processing, transport, storage, packaging, wrapping, exposure for sale, service, or delivery of food. Food Processing,Handling, Food,Processing, Food

Related Publications

A R Boobis, and N J Gooderham, and R J Edwards, and S Murray, and A M Lynch, and M Yadollahi-Farsani, and D S Davies
Species differences in metabolism of heterocyclic aromatic amines, human exposure, and biomonitoring.
October 1994, Environmental health perspectives,
A R Boobis, and N J Gooderham, and R J Edwards, and S Murray, and A M Lynch, and M Yadollahi-Farsani, and D S Davies
Interspecies differences in metabolism of heterocyclic aromatic amines by rat and human P450 1A2.
September 1999, Cancer letters,
A R Boobis, and N J Gooderham, and R J Edwards, and S Murray, and A M Lynch, and M Yadollahi-Farsani, and D S Davies
Metabolism and biodisposition of heterocyclic amines.
January 1990, Progress in clinical and biological research,
A R Boobis, and N J Gooderham, and R J Edwards, and S Murray, and A M Lynch, and M Yadollahi-Farsani, and D S Davies
Metabolism of heterocyclic aromatic amines and strategies of human biomonitoring.
January 1995, Princess Takamatsu symposia,
A R Boobis, and N J Gooderham, and R J Edwards, and S Murray, and A M Lynch, and M Yadollahi-Farsani, and D S Davies
Interindividual differences in the metabolism of xenobiotics.
January 1985, Carcinogenesis; a comprehensive survey,
A R Boobis, and N J Gooderham, and R J Edwards, and S Murray, and A M Lynch, and M Yadollahi-Farsani, and D S Davies
Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6.
November 2002, Drug metabolism reviews,
A R Boobis, and N J Gooderham, and R J Edwards, and S Murray, and A M Lynch, and M Yadollahi-Farsani, and D S Davies
Metabolism of heterocyclic aromatic amines by human hepatocytes and cytochrome P4501A2.
September 2002, Mutation research,
A R Boobis, and N J Gooderham, and R J Edwards, and S Murray, and A M Lynch, and M Yadollahi-Farsani, and D S Davies
Metabolism of heterocyclic amines in cooked food.
January 1990, Progress in clinical and biological research,
A R Boobis, and N J Gooderham, and R J Edwards, and S Murray, and A M Lynch, and M Yadollahi-Farsani, and D S Davies
Interindividual differences in phytochemical metabolism and disposition.
October 2007, Seminars in cancer biology,
A R Boobis, and N J Gooderham, and R J Edwards, and S Murray, and A M Lynch, and M Yadollahi-Farsani, and D S Davies
Metabolism and biomarkers of heterocyclic aromatic amines in humans.
July 2021, Genes and environment : the official journal of the Japanese Environmental Mutagen Society,
Copied contents to your clipboard!